Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT05953064
NA

Effects of DHA-NAT on Postprandial Lipidaemia in Healthy Male Subjects

Sponsor: University Hospital, Gentofte, Copenhagen

View on ClinicalTrials.gov

Summary

This study is an investigator-initiated, randomised, double-blind, placebo-controlled, cross-over human trial investigating the effect of DHA-NAT (C22:6 N-acyl taurine, an endogenous metabolite derived from the omega-3 fatty acid, docosahexaenoic acid) on postprandial plasma triglyceride levels following a high-fat meal.

Official title: Effects of DHA-NAT on Postprandial Lipidaemia in Healthy Male Subjects (FEAST): a Randomised, Double-blind, Placebocontrolled, Crossover Study

Key Details

Gender

MALE

Age Range

18 Years - 30 Years

Study Type

INTERVENTIONAL

Enrollment

20

Start Date

2023-01-01

Completion Date

2025-04-01

Last Updated

2025-03-30

Healthy Volunteers

Yes

Interventions

OTHER

DHA-NAT

Endogenous metabolite of omega-3 fatty acid docosahexaenoic acid

OTHER

Placebo

Vehicle control (H2O) for the intervention used in the experimental arm (DHA-NAT).

Locations (1)

Center for Clinical Metabolic Research, Herlev-Gentofte Hospital

Hellerup, Denmark